Muscular dystrophies are heritable, heterogeneous neuromuscular disorders and include Duchenne and Becker muscular dystrophies (DMD and BMD, respectively). DMD patients exhibit progressive muscle weakness and atrophy followed by exhaustion of muscular regenerative capacity, fibrosis, and eventually disruption of the muscle tissue architecture. In-frame mutations in the dystrophin gene lead to expression of a partially functional protein, resulting in the milder BMD. No effective therapies are available. Stem cell therapy is an attractive method to treat DMD because a small number of cells are required to obtain a therapeutic effect. Here, we discussed about multiple types of myogenic stem cells and their possible use to treat DMD. The identification of a stem cell population providing efficient muscle regeneration is critical for the progression of cell therapy for DMD.
Perspectives of Stem Cell Therapy in Duchenne Muscular Dystrophy / M. Meregalli, A. Farini, M. Belicchi, D. Parolini, L. Cassinelli, P. Razini, C. Sitzia, Y. Torrente. - In: THE FEBS JOURNAL. - ISSN 1742-464X. - 280:17(2013 Sep), pp. 4251-4262. [10.1111/febs.12083]
Perspectives of Stem Cell Therapy in Duchenne Muscular Dystrophy
M. MeregalliPrimo
;A. FariniSecondo
;M. Belicchi;D. Parolini;L. Cassinelli;P. Razini;Y. TorrenteUltimo
2013
Abstract
Muscular dystrophies are heritable, heterogeneous neuromuscular disorders and include Duchenne and Becker muscular dystrophies (DMD and BMD, respectively). DMD patients exhibit progressive muscle weakness and atrophy followed by exhaustion of muscular regenerative capacity, fibrosis, and eventually disruption of the muscle tissue architecture. In-frame mutations in the dystrophin gene lead to expression of a partially functional protein, resulting in the milder BMD. No effective therapies are available. Stem cell therapy is an attractive method to treat DMD because a small number of cells are required to obtain a therapeutic effect. Here, we discussed about multiple types of myogenic stem cells and their possible use to treat DMD. The identification of a stem cell population providing efficient muscle regeneration is critical for the progression of cell therapy for DMD.File | Dimensione | Formato | |
---|---|---|---|
febs.12083.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
295.15 kB
Formato
Adobe PDF
|
295.15 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.